Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Calmark publishes information memorandum in connection with fully guaranteed rights issue

Calmark Sweden AB (publ) (“Calmark” or “the Company”) is presenting an information memorandum today, on the occasion of the rights issue of units that Calmark’s extraordinary general meeting on 6 November 2019 resolved to conduct in accordance with the Board of Directors’s proposal (“the Rights issue”). If the Rights issue is fully subscribed, the Company is initially provided approximately MSEK 24.3 before issuance costs. On full exercise of all associated subscription warrants, the Company will receive between MSEK 10.3 and MSEK 16.2 additionally, before issuance costs. The Rights issue is

NENT Group launches BEAT Diabetes initiative and foundation

· NENT Group’s BEAT Diabetes initiative to focus on Health Tech, Healthy Lifestyles, and Inclusion & Wellbeing · NENT Group to invest at least SEK 2.5 million in BEAT Diabetes Foundation every year from 2020 · Over 1.5 million people living with diabetes across the Nordic region Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, today announced the launch of BEAT Diabetes, a long-term, pan-Nordic initiative to respond to the global diabetes challenge. NENT Group will also launch the BEAT Diabetes Foundation, an independent entity into which NENT

Successful improvements - Svenska Aerogel Holding AB (publ) increases efficiency and reduces use of resources

When transitioning to the new production line, MPP 2019, several improvements have been implemented to increase efficiency, quality and save resources. These projects have been very successful. Water consumtion at Svenska Aerogel plant in Gävle has been reduced by 75% and parts of the raw material usage have been reduced by 30%. This translates to increased productivity and reduces the environmental footprint.Svenska Aerogel's new production line MPP 2019 has been launched and extensive tests are now underway to ensure quality and function. This investment will enable Svenska Aerogel to

EATERIES IN THAILAND WIN MICHELIN STARS FOR 2020

SORN and R-HAAN in the Limelight as the First-Ever Traditional Thai Restaurants in the World to Earn a 2-MICHELIN-Star RatingMichelin today announced the winners of MICHELIN Star and Bib Gourmand distinctions; together with the official launch of the third edition of The MICHELIN Guide in Thailand, entitled The MICHELIN Guide Bangkok, Chiang Mai, Phuket & Phang-Nga 2020. Featured in this latest edition are 282 dining and 74 lodging establishments – with a total of 5 two-star, 24 one-star, and 94 Bib Gourmand eateries. Gwendal Poullennec, International Director of MICHELIN

IRRAS AB publishes Interim Report for the period January to September 2019

IRRAflow Gaining Traction in US ” Since the US is the world’s largest market for neurosurgical procedures, we have focused much of our team’s resources toward supporting a successful early market introduction. Response to our IRRAflow technology remains strong, and our sales funnel is full. Patient treatments with IRRAflow continued to increase, and multiple hospital systems moved from evaluating IRRAflow into the approval and purchasing phase.” Kleanthis G. Xanthopoulos, Ph.D., President and CEO of IRRAS   Third quarter, July – September 2019 · Net revenue amounted to SEK

Xspray Pharma publishes Interim Report Q3, January – September 2019

November 14, 2019  ”It is with a high pace, dedication and broad expertise that Xspray's team continued to drive the development of our furthest progressed product candidate, HyNap-Dasa, towards our first ANDA application. HyNap-Dasa is an amorphous version of Sprycel® (dasatinib). The target of submitting an application to the US FDA during the summer of next year remains firm, as is the planned market launch in the US of HyNap-Dasa in 2021” Per Andersson, CEO Xspray Pharma AB (publ)Significant events during the third quarter 2019 • Xspray announced that the company aims to up-

Pokerlistings.com opens casino vertical on new technical platform

Pokerlistings.com, Net Gaming’s most traffic-generating brand, has been moved to a new technical platform and also expanded to the casino vertical. The new platform gives Pokerlistings.com’s users an improved design with increased user-friendliness.Pokerlistings.com, which was founded in 2003, will now also drive traffic to casino operators. A special casino section of the website offers users guides to game rules, strategies and more for different casino games. Pokerlistings.com will also provide reviews of different online casinos and highlight operators’ offers to players. “The launch

Kesko’s sales grew in October

The sales of Kesko Group’s continuing operations in October 2019 totalled €993.5 million, representing an increase of 2.5% in comparable terms. Reported sales from continuing operations grew by 4.8%.“Reported sales grew in all divisions. Especially in the grocery trade sales growth continued strong,” says Mikko Helander, Kesko’s President and CEO. Sales in the grocery trade totalled €492.6 million in October, an increase of 4.6%. Sales grew in all chains. Sales in the building and technical trade totalled €415.7 million in October, a decrease of 0.4% in comparable terms in local

Inhalation Sciences Sweden AB (publ) releases Interim Report Q3 2019

Interim report in brief: Inhalation Sciences increased sales during the reporting period compared to the corresponding period last year by approx. 229 percent, contracted a CRO to conduct a clinical study of the PreciseInhale system, financed the clinical trial in its entirety through the sale of shares in the associated company Ziccum AB and, during the third quarter, recruited a new CEO: Mr. Manoush Masarrat.Selected financial data July-Sept 2019 Net sales 1,713 KSEK (715) Operating profit -2,747 KSEK (-2,684) Earnings per share before and after dilution SEK -0.36 (-0.31)

Boozt AB’s Q3 report, January 1 – September 30 2019

Net revenue growth of 22% (local currency 22%) in the third quarter with 19% growth in Boozt.com and 90% growth in Booztlet.com. The adjusted EBIT margin improved to -3.6% (-4.0%). For the first nine months net revenue growth was 26% (local currency 25%) with an adjusted EBIT margin of 0.3% (0.3%). CEO Hermann Haraldsson says: ““The softening of the apparel market, especially in Sweden and Denmark, increased over the summer which is reflected in the 19% growth of Boozt.com in the quarter. Booztlet.com however continued the strong trajectory with a 90% growth in the quarter. We are

Sustainability as the foundation for long term value creation

Sustainable forestry [UPM plants over 50 million trees annually.] UPM plants over 50 million trees annually. Sustainability as the foundation for long term value creation (UPM, Helsinki, 14 November 2019 at 9:00 EET) – Sustainability is the only solid foundation for long term value creation. This is the key message that UPM Communication Papers shares to international delegates at the 42nd FIPP World Media Congress, which is held from the 12th to 14th of November in Las Vegas. UPM is the main sponsor of the congress, which is the largest and most high-profile event in the

Interim report 1 January – 30 September 2019

RaySearch Laboratories AB (publ) “Following a record first half year, sales weakened in the third quarter. However, the market situation and demand for our products remain favorable and we have confidence in our strategy” Johan Löf, CEO of RaySearch.   THIRD QUARTER (JULY-SEPTEMBER 2019) ·Net sales SEK 144.3 M (150.5) ·Result after tax SEK -7.5 M (13.5) and earnings per share before/after dilution SEK -0.22 (0.39) ·Operating result SEK -6.3 M (12.4) ·Cash flow SEK -13.5 M (-17.0) ·Order intake SEK 196.8 M (175.7)  NINE MONTHS (JANUARY-

Consistently good quarter

The third quarter: July – September · Net sales increased 23 percent to 292.4 MSEK (237.7). · Order intake increased 57 percent to 199.3 MSEK (127.4). · Order backlog increased 29 percent to 1,556.9 MSEK (1,202.7). · Operating profit increased 25 percent to 31.3 MSEK (25.1). · Net profit after tax increased 21 percent to 23.2 MSEK (19.1). · Earnings per share increased 34 percent to 1.19 SEK (0.89) before and after dilution. · Operating cash flow amounted to -2.2 MSEK (33.1). The nine-month period: January – September · Net sales increased 18 percent to 887.3

Elekta’s Nomination Committee for the 2020 Annual General Meeting

STOCKHOLM, November 14, 2019 – In accordance with the resolution passed by Elekta’s (EKTA-B.ST) Annual General Meeting on August 22, 2019, the Chairman of the Board has convened the Nomination Committee for the 2020 Annual General Meeting by contacting the company’s largest shareholders in terms of votes, in addition to the shareholder or shareholders represented by the Chairman himself. The procedure is described in detail in the notice to the 2019 Annual General Meeting. The Nomination Committee consists of: · Laurent Leksell, in his capacity as Chairman of the Board of Elekta and

Interim report, Q3 2019

Report period July – September, 2019 · Net sales in the quarter amounted to SEK 699 million (634), a growth of 10.2%. In constant currencies and adjusted for acquisitions, the organic growth was 7.9%. · EBITDA amounted to SEK 181 million (129), corresponding to an EBITDA margin of 25.9% (20.3). · EBITA amounted to SEK 96 million (91), corresponding to an EBITA margin of 13.7% (14.3). EBITA includes impairment of tangible assets of SEK -21 million attributable to the canceled concession in Buenos Aires, Argentina. · Profit/loss for the quarter amounted to SEK -26 million (-24)

Quarterly Report July To September 2019

CONTINUED POSITIVE DEVELOPMENT IN ORDER INTAKE AND ORDER BACKLOG - WHILST WORKING TO SECURE A CAPITAL STRUCTURE TO FUEL GROWTHJULY TO SEPTEMBER 2019 — Order Intake was 6.1 MSEK (3.7) and Order Backlog increased to 46.9 MSEK (23.3) — Net Sales totalled 12.8 MSEK (9.6) — Gross Margin increased to 62% (52) — Adjusted EBITDA was -26.9 MSEK (-20.5) — Earnings per share -1.7 SEK EVENTS AFTER THE QUARTER —The Company has worked to secure additional funding in advance of the earnings announcement but this will require some additional time to close. The intent is to secure a

KONE to equip Tianjin Pingan Teda IFC dual tower in China

KONE Corporation, press release, November 14, 2019KONE Corporation, a global leader in the elevator and escalator industry, will deliver 54 elevators and 20 escalators to Tianjin Pingan Teda IFC, a luxury mixed-use development in the city of Tianjin, located in the north-east of China. The building will comprise of two towers rising up to 313 meters and 240 meters in height, including office space, luxurious apartments, and a high-end shopping center.Throughout the new building, a big emphasis is given to sustainability by implementing for example energy saving solutions. Tianjin

Epiroc and Orica partner to automate explosives charging

Stockholm, Sweden: Epiroc, a leading productivity partner for the mining and infrastructure industries, has entered a partnership with world-leading commercial explosives provider Orica (ASX: ORI) to jointly develop a semi-automated explosives delivery system, enabling safer and more productive blasting operations in underground mines.As mines go deeper and ore bodies become more remote the case for blasting automation becomes clearer. The partnership will bring together the deep expertise and experience of two global industry leaders to address the growing demand from customers mining in

Veidekke ASA: Q3 2019 results

Veidekke generated revenues of NOK 9.4 billion in the third quarter, boosting pre-tax profits to NOK 494 million, up NOK 34 million on last year. Veidekke’s construction operations received NOK 5.4 billion in new orders during the quarter, bringing the order book to NOK 33.4 billion as at 30 September.“Overall, this was a steady quarter for Veidekke. We are particularly pleased by the substantial progress made by the industrial operation, which – together with the Norwegian property development operation – delivered an excellent profit performance. We are also satisfied with the Norwegian

Interim Report Q3, 2019

Positive Regulatory Outcome - Enhanced study design“This third quarter of 2019 saw us move steadily towards full recruitment of the NefIgArd study, despite a somewhat slower pace during the summer months. We can now see the finish line and we hope that the next couple of months develop as planned so that we can achieve our ambitious goal.   Due to our interactions with the FDA during the year, we have been able to achieve acceptance by the FDA of a revised design of the confirmatory part of our study, using a more sensitive endpoint, which reduces the number of patients and shortens the

Catella AB – Interim Report January-September 2019

Catella continues to grow and total income increased by 10% in year-on-year terms. The increase was largely due to fixed earnings as a result of continued growth in Property Investment Management which increased assets under management by some SEK 34 Bn year-on-year. Operating profit/loss decreased by SEK 18 M burdened by increased personnel and rental costs in connection with the start-up of new operations in Property Investment Management and new product initiatives, which are an important part of our strategy for continued growth. Net financial income/expense in the quarter was negatively

Orkla ASA: New EVP and CFO at Orkla ASA

Harald Ullevoldsæter has been appointed new Executive Vice President and Chief Financial Officer at Orkla ASA, effective 1 March 2020. He will succeed Jens Bjørn Staff, who is to become CEO of Skagerak Energi. Harald Ullevoldsæter (56) returned to Orkla earlier this year, after having served as Chief Financial Officer of Nortura SA since 2014. From 1996 to 2014, Ullevoldsæter worked at Orkla, where he held a number of executive finance positions, including that of Finance Director and member of the management team of Orkla Brands and Orkla Brands Nordic. Ullevoldsæter also worked as a

Embracer Group AB (publ) publishes Interim Report Q2, July-September 2019: OPERATIONAL EBIT INCREASED 133% TO SEK 241 MILLION

SECOND QUARTER, JULY–SEPTEMBER 2019 (COMPARED TO JULY–SEPTEMBER 2018) · Net sales were SEK 1,259.7 million (1,272.7). Net sales of the Games business area increased 117% to SEK 816.0 million (376.0), whereas the Partner Publishing/Film business area decreased 51% to SEK 443.6 million (896.6) due to the absence of larger releases to match those in the same period last year. Last year’s Partner Publishing revenues included two titles that account for more than the difference to this year’s revenue. · EBITDA increased 95% to SEK 418.1 million (214.8), corresponding to an EBITDA margin of

Lithium can reverse radiation damage after brain tumour treatment

Children who have received radiotherapy for a brain tumour can develop cognitive problems later in life. In their studies on mice, researchers at Karolinska Institutet have now shown that the drug lithium can help to reverse the damage caused long after it has occurred. The study is published in the journal Molecular Psychiatry and the researchers are now planning to test the treatment in clinical trials.Nowadays, four out of five children with a brain tumour survive. In the adult Swedish population, 1 in 600 people have been treated for childhood cancer, about one third of which were brain

There are no items matching the current filter
There are no more items matching the current filter
Back to top